10 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31489252 | Metformin inhibits cervical cancer cell proliferation via decreased AMPK O-GlcNAcylation. | 2019 | 1 |
2 | 27600020 | Activation of AMPK α2 inhibits airway smooth muscle cells proliferation. | 2016 Nov 15 | 2 |
3 | 25955843 | Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells. | 2015 | 1 |
4 | 24809794 | Activation of AMPK inhibits pulmonary arterial smooth muscle cells proliferation. | 2014 Jun | 1 |
5 | 24858012 | Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. | 2014 | 1 |
6 | 22773548 | Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. | 2013 Apr | 1 |
7 | 23974492 | Metformin inhibits lung cancer cells proliferation through repressing microRNA-222. | 2013 Dec | 1 |
8 | 22421144 | Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation. | 2012 Apr 1 | 1 |
9 | 22593441 | Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. | 2012 May | 1 |
10 | 19440038 | Metformin induces unique biological and molecular responses in triple negative breast cancer cells. | 2009 Jul 1 | 1 |